We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

120 hedge funds and large institutions have $214M invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q2 according to their latest regulatory filings, with 120 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $9.83M | Put options by funds: $9.7M

Holders
120
Holders Change
+120
Holders Change %
–
% of All Funds
3.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
120
Increased
–
Reduced
–
Closed
–
Calls
$9.83M
Puts
$9.7M
Net Calls
+$126K
Net Calls Change
+$126K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$678K +$886K +164,855 New
WMSA
52
Weiss Multi-Strategy Advisers
New York
$658K +$860K +160,000 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$633K +$828K +153,900 New
EI
54
EAM Investors
California
$548K +$717K +133,254 New
BA
55
BlackRock Advisors
Delaware
$536K +$702K +130,535 New
TA
56
Teachers Advisors
New York
$527K +$690K +128,246 New
AQR Capital Management
57
AQR Capital Management
Connecticut
$511K +$669K +124,444 New
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$506K +$662K +123,209 New
PTC
59
Peak Ten Capital
New York
$411K +$538K +100,000 New
Bank of America
60
Bank of America
North Carolina
$385K +$503K +93,538 New
State Board of Administration of Florida Retirement System
61
State Board of Administration of Florida Retirement System
Florida
$342K +$448K +83,285 New
NFA
62
Nationwide Fund Advisors
Ohio
$339K +$443K +82,380 New
GT
63
Glenmede Trust
Pennsylvania
$338K +$443K +82,331 New
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
$331K +$433K +80,447 New
ProShare Advisors
65
ProShare Advisors
Maryland
$321K +$420K +78,110 New
Wellington Management Group
66
Wellington Management Group
Massachusetts
$321K +$421K +78,254 New
Swiss National Bank
67
Swiss National Bank
Switzerland
$317K +$415K +77,200 New
KCG
68
Knight Capital Group
$305K +$401K +74,499 New
TC
69
TFS Capital
Pennsylvania
$301K +$393K +73,125 New
VOYA Investment Management
70
VOYA Investment Management
Georgia
$291K +$381K +70,914 New
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$290K +$378K +70,363 New
AIG
72
American International Group
New York
$264K +$345K +64,131 New
MC
73
Middleton & Co
Massachusetts
$260K +$340K +63,150 New
MCM
74
Munder Capital Management
Michigan
$251K +$328K +60,972 New
Wells Fargo
75
Wells Fargo
California
$221K +$288K +53,636 New
1 2
3
4 5

ASTX Hedge Fund Activity: Q2 2013 in Review

120 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q2 2013, worth a combined $214M.

Buyers outnumbered sellers: 120 funds opened new ASTX positions and 0 closed out — a net gain of 120 holders — while 0 added to existing stakes and 0 trimmed.

  • 120 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $214M of ASTEX PHARMACEUTICALS, INC COM stock for Q2 2013.
  • 120 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q2 2013 and 0 closed out, a net change of +120 holders.

Based on aggregated 13F filings for Q2 2013.